Fioretto P, Keane W F, Kasiske B L, O'Donnell M P, Klein D J
Department of Pediatrics, University of Minnesota Medical School, Minneapolis.
J Am Soc Nephrol. 1993 Apr;3(10):1694-704. doi: 10.1681/ASN.V3101694.
Glomerular proteoglycans (PG) are important in modulating extracellular matrix assembly and glomerular permselectivity. In the obese Zucker rat, an experimental model of non-insulin dependent diabetes mellitus, expansion of the mesangial matrix, and microalbuminuria occur before the development of overt renal disease. The in vivo incorporation of (35S)sulfate into glomerular PG in 12-wk-old obese Zucker rats at the onset of microalbuminuria was compared with that of 12-wk-old lean Zucker rats. Specific (35S)sulfate incorporation into glomerular PG over 8 h was increased by 57% in obese rats compared with lean rats, suggesting increased PG synthesis. However, at variance with the observation in experimental models of insulin-dependent diabetes mellitus, the proportion of total glomerular (35S)PG released by heparin treatment was unchanged. Heparan sulfate (HS)-PG constituted over 60% of radiolabeled de novo synthesized glomerular PG. Similar proportions of HS-PG were extracted from the glomeruli of obese and lean rats. Isolated glomeruli spontaneously released two HS-PG, which constituted approximately 30% of total glomerular (35S)PG. On the basis of their chromatographic and electrophoretic patterns, these PG were similar in obese and lean rats. Heparin treatment of isolated glomeruli released an additional HS-PG, which appeared to be derived primarily from the glomerular extracellular matrix compartment and not from the detergent soluble cell fraction. Heparin-releasable HS-PG from both the lean and obese Zucker rats eluted at a KAV of 0.31 from Sepharose CL-6B chromatographic columns, indicating a hydrodynamic size similar to that reported for glomerular basement membrane HS-PG. However, gel electrophoresis demonstrated faster migration of the HS-PG released by heparin from the glomeruli of obese Zucker rats, suggesting increased electronegativity. Thus, early in the course of nephropathy in the obese Zucker rat, there is increased glomerular PG synthesis with no change in the proportions of the constitutively releasable and heparin-releasable HS-PG. Whether electrophoretic abnormalities of the heparin-releasable HS-PG observed in the obese rats contribute to the development of albuminuria and/or mesangial matrix expansion remains to be established.
肾小球蛋白聚糖(PG)在调节细胞外基质组装和肾小球滤过选择性方面具有重要作用。在肥胖 Zucker 大鼠(一种非胰岛素依赖型糖尿病的实验模型)中,在明显肾脏疾病发生之前就会出现系膜基质扩张和微量白蛋白尿。将 12 周龄肥胖 Zucker 大鼠在微量白蛋白尿开始时肾小球 PG 中(35S)硫酸盐的体内掺入情况与 12 周龄瘦 Zucker 大鼠进行比较。与瘦大鼠相比,肥胖大鼠在 8 小时内肾小球 PG 中特异性(35S)硫酸盐掺入量增加了 57%,表明 PG 合成增加。然而,与胰岛素依赖型糖尿病实验模型中的观察结果不同,肝素处理后释放的总肾小球(35S)PG 的比例没有变化。硫酸乙酰肝素(HS)-PG 占新合成的放射性标记肾小球 PG 的 60%以上。从肥胖和瘦大鼠的肾小球中提取的 HS-PG 比例相似。分离的肾小球自发释放两种 HS-PG,约占总肾小球(35S)PG 的 30%。根据它们的色谱和电泳图谱,这些 PG 在肥胖和瘦大鼠中相似。肝素处理分离的肾小球会释放另一种 HS-PG,它似乎主要来源于肾小球细胞外基质部分,而不是去污剂可溶的细胞部分。来自瘦和肥胖 Zucker 大鼠的肝素可释放 HS-PG 在 Sepharose CL-6B 色谱柱上以 0.31 的 KAV 洗脱,表明其流体力学大小与报道的肾小球基底膜 HS-PG 相似。然而,凝胶电泳显示肝素从肥胖 Zucker 大鼠肾小球中释放的 HS-PG 迁移速度更快,表明其电负性增加。因此,在肥胖 Zucker 大鼠肾病过程的早期,肾小球 PG 合成增加,而组成性可释放和肝素可释放 HS-PG 的比例没有变化。肥胖大鼠中观察到的肝素可释放 HS-PG 的电泳异常是否导致白蛋白尿和/或系膜基质扩张的发生仍有待确定。